BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25096844)

  • 1. [Dermatological reactions in patients in antineoplastic therapy].
    Prasad SC; Vestergaard H; Bygum A
    Ugeskr Laeger; 2014 May; 176(11):. PubMed ID: 25096844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology and management of dermatologic toxicities associated with anti-EGFR therapy.
    Fox LP
    Oncology (Williston Park); 2006 Apr; 20(5 Suppl 2):26-34. PubMed ID: 16736980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous reactions to chemotherapy and their management.
    Wyatt AJ; Leonard GD; Sachs DL
    Am J Clin Dermatol; 2006; 7(1):45-63. PubMed ID: 16489842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse mucocutaneous reactions related to chemotherapeutic agents: part II.
    Criado PR; Brandt HR; Moure ER; Pereira GL; Sanches Júnior JA
    An Bras Dermatol; 2010; 85(5):591-608. PubMed ID: 21152783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic docetaxel chemotherapy induced skin toxicities in breast cancer patient.
    Elalami I; Ichou M
    Pan Afr Med J; 2016; 24():164. PubMed ID: 27826363
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous reactions to pediatric cancer treatment: Part I. Conventional chemotherapy.
    Sous D; Armstrong AE; Huang JT; Shah S; Carlberg VM; Coughlin CC
    Pediatr Dermatol; 2021 Jan; 38(1):8-17. PubMed ID: 33170534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Skin changes as a result of targeted therapies in oncology patients: cutaneous side effects of targeted therapies in oncology patients].
    Kähler KC; Hauschild A
    Hautarzt; 2009 May; 60(5):433-40. PubMed ID: 19430753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New agents, new rashes: an update on skin complications from cancer chemotherapy.
    Patiyil S; Chan SN; Jatoi A
    Curr Oncol Rep; 2006 Jul; 8(4):269-74. PubMed ID: 17254526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Reactions to Targeted Therapy.
    Lee JJ; Kroshinsky D; Hoang MP
    Am J Dermatopathol; 2017 Feb; 39(2):67-82. PubMed ID: 28134724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects.
    Patrizi A; Venturi M; Dika E; Maibach H; Tacchetti P; Brandi G
    Cutan Ocul Toxicol; 2014 Mar; 33(1):1-6. PubMed ID: 23638756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous Adverse Reactions of Anticancer Agents.
    Kaul S; Kaffenberger BH; Choi JN; Kwatra SG
    Dermatol Clin; 2019 Oct; 37(4):555-568. PubMed ID: 31466595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-induced iatrogenic injury of skin: new drugs and new concepts.
    Choi JN
    Clin Dermatol; 2011; 29(6):587-601. PubMed ID: 22014981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatological toxicity associated with targeted therapies in cancer: optimal management.
    Peuvrel L; Dréno B
    Am J Clin Dermatol; 2014 Oct; 15(5):425-44. PubMed ID: 25117153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of the cutaneous side effects of chemotherapies and targeted therapies].
    Delyon J; Gerard M; Nicodeme M; Fromantin I; Loirat D
    Soins; 2015 Jun; (796):17-24. PubMed ID: 26146316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic reactions to chemotherapeutic agents.
    Fitzpatrick JE; Hood AF
    Adv Dermatol; 1988; 3():161-83. PubMed ID: 2978953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse cutaneous reactions to medications.
    Kroshinsky D
    Clin Dermatol; 2020; 38(6):605-606. PubMed ID: 33341194
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous toxicities of cancer therapy.
    Alley E; Green R; Schuchter L
    Curr Opin Oncol; 2002 Mar; 14(2):212-6. PubMed ID: 11880713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology.
    Dreno B; Bensadoun RJ; Humbert P; Krutmann J; Luger T; Triller R; Rougier A; Seité S
    J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1071-80. PubMed ID: 23368717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer: Part II. Targeted therapy.
    Reyes-Habito CM; Roh EK
    J Am Acad Dermatol; 2014 Aug; 71(2):217.e1-217.e11; quiz 227-8. PubMed ID: 25037801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy and cutaneous toxicities: implications for oncology nurses.
    Viale PH
    Semin Oncol Nurs; 2006 Aug; 22(3):144-51. PubMed ID: 16893743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.